Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Response from CEO, CHAI about the Quick Start program in November 2016
Response from CEO, CHAI about the Quick Start program in November 2016
Please click here
December 21, 2016
/
News
Share
the Post
Related
Posts
Asia Pacific Situational Updates on Generic DAAs – June 2017
Progress report on access to hepatitis C treatment, WHO March 2018
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Hepatitis C Treatment Snapshots: Daclatasvir
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
